Journal of the American Society of Nephrology : JASN

publication venue for

Regulatory and Payment Changes Addressing the Social Determinants of Kidney Health. 2024
Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial.. 35. 2023
Optimal Care for Kidney Health: Development of a Merit-based Incentive Payment System (MIPS) Value Pathway. 2023
Economic Impact of a Change in Medicaid Coverage Policy for Dialysis Care of Undocumented Immigrants. 2023
Rare Single Nucleotide and Copy Number Variants and the Etiology of Congenital Obstructive Uropathy: Implications for Genetic Diagnosis. 2023
A Microsimulation Study of the Cost-Effectiveness of Hepatitis C Virus Screening Frequencies in Hemodialysis Centers.. 34. 2023
The Importance of Maintaining Reproductive Choices for Kidney Transplant Recipients.. 34. 2023
The ABCD of Kidney Allograft Pathology-The Beginning of the Beginning.. 33. 2022
Premature Death in Kidney Transplant Recipients: The Time for Trials is Now.. 33. 2022
Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.. 33. 2022
Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing. 2021
Plasma Proteomics of Renal Function: A Trans-ethnic Meta-analysis and Mendelian Randomization Study. 2021
Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy.. 32. 2021
Racial and Neighborhood-Level Disparities in COVID-19 Incidence among Patients on Hemodialysis in New York City.. 32. 2021
Ensuring the Equitable Advancement of American Kidney Health-the Need to Account for Socioeconomic Disparities in the ESRD Treatment Choices Model.. 32. 2020
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.. 32. 2020
Effect of Neighborhood Food Environment and Socioeconomic Status on Serum Phosphorus Level for Patients on Chronic Dialysis.. 31. 2020
Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.. 31. 2020
COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.. 31. 2020
Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23.. 31. 2020
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.. 31. 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.. 31. 2020
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.. 31. 2019
Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.. 30. 2019
National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.. 30. 2019
A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.. 30. 2019
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.. 30. 2019
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.. 30. 2019
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.. 30. 2019
Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.. 29. 2018
Effect of Bariatric Surgery on CKD Risk.. 29. 2018
The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.. 29. 2017
Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.. 29. 2017
Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease.. 28. 2017
Pregnancy-Induced Sensitization Promotes Sex Disparity in Living Donor Kidney Transplantation.. 28. 2017
Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2.. 28. 2017
Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.. 28. 2017
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.. 28. 2016
Genetic Variants Associated with Circulating Parathyroid Hormone.. 28. 2016
Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.. 28. 2016
Partitioning-Defective 1a/b Depletion Impairs Glomerular and Proximal Tubule Development.. 27. 2016
A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population.. 27. 2015
Urine Metabolite Profiles Predictive of Human Kidney Allograft Status.. 27. 2015
Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.. 27. 2015
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.. 26. 2015
Contrasting Cholesterol Management Guidelines for Adults with CKD.. 26. 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.. 26. 2014
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.. 26. 2014
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.. 26. 2014
Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies.. 26. 2014
CKD and the risk of incident cancer.. 25. 2014
Autophagy regulates TGF-β expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction.. 25. 2014
TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.. 25. 2014
Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction.. 25. 2014
The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.. 25. 2013
Fibroblast growth factor-23 and cardiovascular events in CKD.. 25. 2013
Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis.. 25. 2013
ABIN1 dysfunction as a genetic basis for lupus nephritis.. 24. 2013
The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.. 24. 2013
Genomic biomarkers correlate with HLA-identical renal transplant tolerance.. 24. 2013
Mineral metabolites and CKD progression in African Americans.. 24. 2012
Effects of phosphate binders in moderate CKD.. 23. 2012
Discriminants of prevalent fractures in chronic kidney disease.. 22. 2011
Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.. 22. 2011
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.. 22. 2011
Magnesium modulates ROMK channel-mediated potassium secretion.. 21. 2010
Pendrin modulates ENaC function by changing luminal HCO3-.. 21. 2010
Low socioeconomic status associates with higher serum phosphate irrespective of race.. 21. 2010
Overexpression of VEGF165b in podocytes reduces glomerular permeability.. 21. 2010
Bone mass and microarchitecture in CKD patients with fracture.. 21. 2010
Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.. 20. 2009
Nephrin deficiency activates NF-kappaB and promotes glomerular injury.. 20. 2009
Plasma gelsolin and circulating actin correlate with hemodialysis mortality.. 20. 2009
Phosphorus binders and survival on hemodialysis.. 20. 2008
Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells.. 19. 2008
Ferumoxytol for treating iron deficiency anemia in CKD.. 19. 2008
Impact of activated vitamin D and race on survival among hemodialysis patients.. 19. 2008
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.. 19. 2008
Risk of kidney injury following oral phosphosoda bowel preparations.. 18. 2007
Reduced systolic myocardial function in children with chronic renal insufficiency.. 18. 2007
Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function.. 18. 2006
Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2.. 17. 2006
Left ventricular geometry in children with mild to moderate chronic renal insufficiency.. 17. 2005
Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.. 16. 2005
Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.. 16. 2005
Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters.. 16. 2005
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.. 16. 2005
Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.. 16. 2005
Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.. 16. 2005
Activated injectable vitamin D and hemodialysis survival: a historical cohort study.. 16. 2005
Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen.. 15. 2004
Differential risk of hypertensive disorders of pregnancy among Hispanic women.. 15. 2004
Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury.. 14. 2003
Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.. 14. 2003
A role for uric acid in the progression of renal disease.. 13. 2002
Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression.. 13. 2002
Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome.. 13. 2002
Morphologic and functional magnetic resonance imaging of renal artery stenosis: a multireader tricenter study.. 13. 2002
Cyclosporine A inhibits the adaptive responses to hypertonicity: a potential mechanism of nephrotoxicity.. 12. 2001
Countervailing influence of tumor necrosis factor-alpha and nitric oxide in endotoxemia.. 12. 2001
Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant mice.. 12. 2001
CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES.. 12. 2001
Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury.. 9. 1998
Localization of ROMK channels in the rat kidney.. 8. 1997
Tenascin is synthesized and secreted by rat mesangial cells in culture and is present in extracellular matrix in human glomerular diseases.. 4. 1994
Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney.. 4. 1994
Improvement of plasma lipoprotein profiles during high-flux dialysis.. 3. 1993
Clusterin production in the obstructed rabbit kidney: correlations with loss of renal function.. 3. 1992
Comparative Health Care Spending for Dialysis: An Example of Public Cost Containment?. 32. 2021
Sex and Kidney Transplantation: Why Can't a Woman Be More Like a Man?. 28. 2017
Urine CXCL10/IP-10 Fingers Ongoing Antibody-Mediated Kidney Graft Rejection.. 26. 2015
The biomarker niche for fibroblast growth factor 23 testing in CKD.. 26. 2014
In search of the fountain of youth.. 25. 2014
Partial answers from partial Klotho deficiency.. 23. 2012
Phosphate REINs in the renoprotective benefit of ACE inhibition.. 22. 2011
REIN on obesity, proteinuria and CKD.. 22. 2011
The not-so-sweet side of fructose.. 20. 2009
Active vitamin D and survival.. 19. 2008
The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma. 2016
Overview: mechanisms of hypertension: cells, hormones, and the kidney. 2004
Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective. 2003
Role of the microvascular endothelium in progressive renal disease. 2002
Physiologic and immunologic hurdles to xenotransplantation. 2001
Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery. 2020
Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. 2018
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. 2015
Forging forward with 10 burning questions on FGF23 in kidney disease. 2010

VIVO Weill Cornell Medical College

Journal of the American Society of Nephrology : JASN Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)